SONORAN BIOSCIENCES INC
SB Gel, a sustained-release carrier formulation that extends local anesthetic (bupivacaine) delivery for multiple days postoperatively
- Sector
- Medtech
- Headquarters
- Chandler, AZ
- Total capital
- $9M
- Federal grants
- $9M
- 9 awards · 2016–2024
- Rank in peer group#17 of 36
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 3 pending · first 2021
- Rank in peer group#8 of 36
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Extended-release injectable gel for multi-day treatment of postoperative pain$1.5M
- Federal grantHealth and Human S · Phase I · Sustained-release gel for multi-day control of postoperative pain$260K
- Federal grantHealth and Human S · Phase I · Sustained-release gel for multi-day control of postoperative pain$260K
- Federal grantHealth and Human S · Phase II · Sustained release gel enabling one-stage treatment of prosthetic joint infection$1.0M
- Federal grantHealth and Human S · Phase II · Sustained release gel enabling one-stage treatment of prosthetic joint infection$2M
- Federal grantHealth and Human S · Phase II · Sustained release gel enabling one-stage treatment of prosthetic joint infection$1M
- Federal grantHealth and Human S · Phase II · Sustained release gel enabling one-stage treatment of prosthetic joint infection$919K
Show 2 earlier federal awards
- Federal grantHealth and Human S · Phase II · Sustained release gel enabling one stage treatment of prosthetic joint infection$1.5M
- Federal grantHealth and Human S · Phase II · Sustained release gel enabling one-stage treatment of prosthetic joint infection$565K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 36 peers
Line = medianMedtech · Material
- Federal grants#17 · top 47%
- Granted patents#8 · top 22%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 5- GrantedTemperature-responsive Degradable HydrogelsUSPTOUS 12,097,260
- GrantedTemperature-responsive Degradable HydrogelsUSPTOUS 11,173,210
- PendingTemperature-responsive Degradable HydrogelsUSPTOApplication 62838176
Show all 5 patent records
- Temperature-responsive Degradable HydrogelsSep 24, 2024 · US 12,097,260Granted
- Temperature-responsive Degradable HydrogelsNov 16, 2021 · US 11,173,210Granted
- Temperature-responsive Degradable HydrogelsApplication 62838176Pending
- Temperature-responsive Degradable HydrogelsApplication PCTUS2018057398Pending
- Formulation of temperature-responsive resorbable hydrogels for improved shelf life and drug loadingApplication 62576269Pending
Related companies, and why
- VANISH THERAPEUTICS INCSimilar federal contract value in Medtech · null in contracts
- NeuroVista CorpSimilar federal contract value in Medtech · null in contracts
- TRITONX INC.Similar federal contract value in Medtech · null in contracts
- VIGOROUS MIND INCSimilar federal contract value in Medtech · null in contracts
- WEARIFI, INC.Similar federal contract value in Medtech · null in contracts
- AIROMATIX INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .